Paul M. Mendelman

Paul M.
Mendelman worked as a Director of Clinical Research Infectious Diseases at Merck & Co., Inc. from 1991 to 1996.
He then worked as a Vice President of Clinical Development at MedImmune LLC from 2002 to 2005.
He also held the position of Vice President of Clinical Development at MedImmune Vaccines, Inc. and Senior Vice President of Clinical Development at Telik, Inc. He was the Chief Medical Officer & EVP at LigoCyte Pharmaceuticals, Inc. and later became the Chief Medical Officer at Aridis Pharmaceuticals, Inc. He returned to Aridis Pharmaceuticals, Inc. in 2019 as the Chief Medical Officer until 2020.
From 2012 to 2017, he worked as the Vice President of Medical at Takeda Vaccines, Inc. Dr. Mendelman received his undergraduate and doctorate degrees from The Ohio State University.